Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639223 · ClinicalTrials.gov registry record · Phase 2
Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT00639223: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00639223 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00639223, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
This study will examine the effect of red yeast rice extract compared to pravastatin on muscle related complaints in individuals with high cholesterol who have previously been unable to tolerate statin medications due to muscle pain. The study will determine whether red yeast is associated with a lower level of muscle related complaints compared to pravastatin.
Interventions
- DRUG Pravastatin
- DIETARY_SUPPLEMENT Red Yeast Rice
- BEHAVIORAL Lifestyle modification program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00639223
The ClinicalTrials.gov registry entry for NCT00639223 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Pravastatin is the first listed.
NCT00639223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00639223 about?
NCT00639223 is a clinical study titled "Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance". This study will examine the effect of red yeast rice extract compared to pravastatin on muscle related complaints in individuals with high cholesterol who have previously been unable to tolerate statin medications due to muscle pain. The study will determine whether red yeast is associated with a lo...
What is the current status of trial NCT00639223?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2008-01. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00639223?
The interventions under investigation include: Pravastatin (DRUG), Red Yeast Rice (DIETARY_SUPPLEMENT), Lifestyle modification program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00639223?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.